Netherlands· NL-28638d5ad895
Vyloy 100 mg poeder voor concentraat voor oplossing voor infusie
A zolbetuximab product containing zolbetuximab, registered in Netherlands by Astellas Pharma Europe B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Zolbetuximab is registered in 13 of 19 countries.
Countries holding a registration under ATC L01FX31 (zolbetuximab), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Zolbetuximab · ATC L01FX31
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ZOLBETUXIMAB
- Manufacturer
- Astellas Pharma Europe B.V.
- Country
- Netherlands (NL)
- ATC code
- L01FX31
- ATC class
- Zolbetuximab
- Defined daily dose
- 51.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/24/1856
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zolbetuximab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceVYLOY 100 mg, poudre pour solution à diluer pour perfusionASTELLAS PHARMA EUROPE (PAYS-BAS)
- United StatesVYLOYAstellas Pharma US, Inc.
- SwitzerlandVyloy 100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungAstellas Pharma AG
- CzechiaVYLOYAstellas Pharma Europe B.V., Leiden
- BelgiumVyloy 100 mgAstellas Pharma Europe
- United KingdomVyloy 100mg powder for concentrate for solution for infusion vialsAstellas Pharma Ltd
- SpainVYLOY 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONAstellas Pharma Europe B.V.
- FinlandVyloyAstellas Pharma Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyloy
- Liechtenstein · Vyloy
- Norway · Vyloy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2e4ebb4f-0142-408b-8aa6-0a21b97726c7 GET /v1/drugs/2e4ebb4f-0142-408b-8aa6-0a21b97726c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/vyloy-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Zolbetuximab",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp131783",
"excipients": [
"ARGININE, (L-)",
"FOSFORZUUR (E 338)",
"POLYSORBAAT 80 (E 433)",
"SACCHAROSE",
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"ZOLBETUXIMAB"
],
"leaflet_url": null,
"authorised_at": "2024/09/19",
"procedure_number": "EMEA/H/C/005868",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/24/1856",
"additional_monitoring": "Y"
}See everything about zolbetuximab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.